Literature DB >> 28847586

Assessment of mortality by qSOFA in patients with sepsis outside ICU: A post hoc subgroup analysis by the Japanese Association for Acute Medicine Sepsis Registry Study Group.

Yutaka Umemura1, Hiroshi Ogura2, Satoshi Gando3, Shigeki Kushimoto4, Daizoh Saitoh5, Toshihiko Mayumi6, Seitaro Fujishima7, Toshikazu Abe8, Hiroto Ikeda9, Joji Kotani10, Yasuo Miki11, Shin-Ichiro Shiraishi12, Atsushi Shiraishi13, Koichiro Suzuki14, Yasushi Suzuki15, Naoshi Takeyama16, Kiyotsugu Takuma17, Ryosuke Tsuruta18, Yoshihiro Yamaguchi19, Norio Yamashita20, Naoki Aikawa21.   

Abstract

Quick sequential organ failure assessment (qSOFA) was proposed in the new sepsis definition (Sepsis-3). Although qSOFA was created to identify patients with suspected infection and likely to have poor outcomes, the clinical utility of qSOFA to screen sepsis has not been fully evaluated. We investigated the number of patients diagnosed as having severe sepsis who could not be identified by the qSOFA criteria and what clinical signs could complement the qSOFA score. This retrospective analysis of a multicenter prospective registry included adult patients with severe sepsis diagnosed outside the intensive care unit (ICU) by conventional criteria proposed in 2003. We conducted receiver operating characteristic (ROC) analyses to assess the predictive value for in-hospital mortality and compared clinical characteristics between survivors and non-survivors with qSOFA score ≤ 1 point (qSOFA-negative). Among 387 eligible patients, 63 (16.3%) patients were categorized as qSOFA-negative, and 10 (15.9%) of these patients died. The area under the ROC curve for the qSOFA score was 0.615, which was superior to that for the systemic inflammatory response syndrome score (0.531, P = 0.019) but inferior to that for the SOFA score (0.702, P = 0.005). Multivariate logistic regression analysis showed that hypothermia might be associated with poor outcome independently of qSOFA criteria. Our findings suggested that qSOFA had a suboptimal level of predictive value outside the ICU and could not identify 16.3% of patients who were once actually diagnosed with sepsis. Hypothermia might be associated with an increased risk of death that cannot be identified by qSOFA.
Copyright © 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Criteria; Hypothermia; Organ dysfunction scores; Registries; Sepsis

Mesh:

Year:  2017        PMID: 28847586     DOI: 10.1016/j.jiac.2017.07.005

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  5 in total

1.  qSOFA score for prediction of sepsis outcome in emergency department.

Authors:  Kavous Shahsavarinia; Payman Moharramzadeh; Reza Jamal Arvanagi; Ata Mahmoodpoor
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

Review 2.  Comparison of Prognostic Accuracy of the quick Sepsis-Related Organ Failure Assessment between Short- & Long-term Mortality in Patients Presenting Outside of the Intensive Care Unit - A Systematic Review & Meta-analysis.

Authors:  Toh Leong Tan; Ying Jing Tang; Ling Jing Ching; Noraidatulakma Abdullah; Hui-Min Neoh
Journal:  Sci Rep       Date:  2018-11-12       Impact factor: 4.379

3.  The ability of an improved qSOFA score to predict acute sepsis severity and prognosis among adult patients.

Authors:  Yiqin Xia; LiQun Zou; Dongze Li; Qin Qin; Hai Hu; Yiwu Zhou; Yu Cao
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

4.  Lactate-enhanced-qSOFA (LqSOFA) score is superior to the other four rapid scoring tools in predicting in-hospital mortality rate of the sepsis patients.

Authors:  Sijia Liu; Chengqi He; Weilue He; Tian Jiang
Journal:  Ann Transl Med       Date:  2020-08

5.  Prognostic Accuracy of SOFA, qSOFA, and SIRS for Mortality Among Emergency Department Patients with Infections.

Authors:  S M Osama Bin Abdullah; Rune Husås Sørensen; Finn Erland Nielsen
Journal:  Infect Drug Resist       Date:  2021-07-20       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.